AnaptysBio, Inc. (ANAB) vs Phibro Animal Health Corporation (PAHC)
A side-by-side comparison of AnaptysBio, Inc. and Phibro Animal Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANAB
AnaptysBio, Inc.
$48.57HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
PAHC
Phibro Animal Health Corporation
$37.06HealthcareDelayed quote: Oct 6, 2026, 11:53 AM EDT
Total return — ANAB vs PAHC
growth of $100 · dividends reinvested · last 10yANAB +334.2% (+15.8%/yr)PAHC +64.4% (+5.1%/yr)ANAB compounded faster over this window
ANAB PAHC
ANAB vs PAHC: by the numbers
- •PAHC is the larger company ($1.50B vs $1.44B market cap).
- •ANAB trades at the lower trailing earnings multiple (9.04 vs 15.19 P/E), one valuation lens rather than an overall verdict.
- •ANAB converts more revenue to profit (82.37% vs 6.57% net margin).
- •ANAB grew revenue faster over the past five years (18.60% vs 12.75% CAGR).
- •PAHC pays a dividend (1.29% yield), while ANAB has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ANAB | PAHC |
|---|---|---|
| P/E ratio | 9.04 | 15.19 |
| Forward P/E | N/A | 10.59 |
| PEG ratio | N/A | 1.19 |
| P/S ratio | 6.05 | 0.99 |
| P/B ratio | 135.86 | 3.90 |
| EV / EBITDA | 11.59 | 8.92 |
| FCF yield | 1.25% | 0.66% |
Profitability
| Metric | ANAB | PAHC |
|---|---|---|
| Gross margin | 98.97% | 33.71% |
| Operating margin | 20.42% | 13.07% |
| Net margin | 82.37% | 6.57% |
| ROE | 1849.06% | 25.87% |
| ROIC | 47.55% | 11.91% |
Dividends
| Metric | ANAB | PAHC |
|---|---|---|
| Dividend yield | N/A | 1.29% |
| Payout ratio | N/A | 19.67% |
Growth (annualized)
| Metric | ANAB | PAHC |
|---|---|---|
| Revenue CAGR (5Y) | 18.60% | 12.75% |
| EPS CAGR (5Y) | N/A | 12.92% |
| FCF CAGR (5Y) | 27.41% | -12.27% |
| Total return CAGR (5Y) | 21.54% | 14.40% |
Frequently asked
- Which has the lower trailing P/E, ANAB or PAHC?
- ANAB has the lower trailing P/E: ANAB trades at 9.04 and PAHC at 15.19. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ANAB or PAHC?
- Over the past five years, ANAB grew revenue faster — ANAB at a 18.60% CAGR versus PAHC at 12.75%.
- Does ANAB or PAHC pay a bigger dividend?
- PAHC pays a dividend (1.29% yield), while ANAB has no payments in the available dividend history.
- Is ANAB or PAHC more profitable?
- ANAB runs the higher net margin — ANAB at 82.37% versus PAHC at 6.57%.
- How have ANAB and PAHC total returns compared?
- Over the past 5 years, ANAB delivered 21.54% and PAHC delivered 14.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AnaptysBio P/E ratioPhibro Animal Health P/E ratioPhibro Animal Health dividend yieldAnaptysBio ROEPhibro Animal Health ROEAnaptysBio operating marginPhibro Animal Health operating marginAnaptysBio revenue growthPhibro Animal Health revenue growthAnaptysBio free cash flowPhibro Animal Health free cash flow
AnaptysBio & Phibro Animal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.